WeVote
Log In

Bill

Bill

HD 3233

An Act relative to assessing the feasibility of in-state drug manufacturing

194th Legislature (2025-2026) Introduced by Marjorie Decker

Massachusetts will study feasibility of state-based pharmaceutical manufacturing to potentially reduce drug costs and improve supply chain security.

Senate concurred
0
WeVote Research Nonpartisan
Bill Summary · HD 3233

Legislative bill overview

HD 3233 directs Massachusetts to conduct a comprehensive feasibility study on establishing in-state pharmaceutical manufacturing capabilities. The bill requires examination of production costs, regulatory requirements, market demand, and potential locations for manufacturing facilities within the state.

Why is this important

In-state drug manufacturing could reduce prescription drug costs for Massachusetts residents, increase supply chain resilience, and create manufacturing jobs. The feasibility study is a preliminary step toward potentially addressing pharmaceutical affordability and supply vulnerabilities that became apparent during recent health crises.

Potential points of contention

  • Cost and funding: The study itself requires state resources, and actual manufacturing facilities would require substantial capital investment with uncertain return on investment
  • Market viability: Massachusetts has high labor and real estate costs compared to existing pharmaceutical manufacturing hubs, raising questions about economic competitiveness
  • Scope limitations: State-level manufacturing cannot realistically address the full range of drugs needed; prioritization decisions would be controversial
  • Timeline and complexity: Pharmaceutical manufacturing involves complex FDA regulations and infrastructure requirements that could make implementation impractical
  • Public vs. private role: Unclear whether the state would operate facilities or incentivize private manufacturers, each carrying different risks and benefits

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.